Cargando…

Grand Challenges in Allergen Immunotherapy

Detalles Bibliográficos
Autor principal: Cox, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974864/
https://www.ncbi.nlm.nih.gov/pubmed/35387004
http://dx.doi.org/10.3389/falgy.2021.710345
_version_ 1784680291021881344
author Cox, Linda
author_facet Cox, Linda
author_sort Cox, Linda
collection PubMed
description
format Online
Article
Text
id pubmed-8974864
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89748642022-04-05 Grand Challenges in Allergen Immunotherapy Cox, Linda Front Allergy Allergy Frontiers Media S.A. 2021-08-05 /pmc/articles/PMC8974864/ /pubmed/35387004 http://dx.doi.org/10.3389/falgy.2021.710345 Text en Copyright © 2021 Cox. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Allergy
Cox, Linda
Grand Challenges in Allergen Immunotherapy
title Grand Challenges in Allergen Immunotherapy
title_full Grand Challenges in Allergen Immunotherapy
title_fullStr Grand Challenges in Allergen Immunotherapy
title_full_unstemmed Grand Challenges in Allergen Immunotherapy
title_short Grand Challenges in Allergen Immunotherapy
title_sort grand challenges in allergen immunotherapy
topic Allergy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974864/
https://www.ncbi.nlm.nih.gov/pubmed/35387004
http://dx.doi.org/10.3389/falgy.2021.710345
work_keys_str_mv AT coxlinda grandchallengesinallergenimmunotherapy